50 / 112
48
WFSBP 2015
Scientific Programme
|
Tuesday, 16 June 2015
ES-02
Educational Session
14:00–18:30
MC 3.3 Room
Session 2 on pharmacological treatment
Chair:
Lakshmi Yatham, Canada
Co-Chair: David Castle, Australia
ES-02-001
Pharmacological treatment of anxiety disorders
Christer Allgulander, Sweden
ES-02-002
Pharmacological treatment of unipolar disorders
Michael Bauer, Germany
ES-02-003
Pharmacological treatment of bipolar disorders
Lakshmi Yatham, Canada
ES-02-004
Pharmacological treatment of psychotic disorders
Peter Falkai, Germany
ES-02-005
How to manage metabolic disorders associated to psy-
chotropic drugs
David Castle, Australia
FC-10
Free Communications
08:30–10:00
Kokkali Room
Addiction
Chair:
Aviv Weinstein, Israel
Co-Chair: Elias Tzavellas, Greece
FC-10-001
Methamphetamine induces dopamine neurons degenera-
tion evidenced by silver staining and causes motor defects
in mice
Rosario Moratalla, Spain
S. Ares-Santos, N. Granado
FC-10-002
Dopaminergic modulation of value-based decision making
and subjective well-being
Nikolina Skandali, United Kingdom
R. Rutledge, P. Dayan, R. Dolan
FC-10-003
The glucocorticoid receptor system is altered in co-
caine-withdrawn adolescent rats
Lucia Caffino, Italy
G. Giuseppe, C. Malpighi, C. Michilli, F. Fumagalli
FC-10-004
Type of benzodiazepine and clinical presentation of ben-
zodiazepine dependence
Olivera Zikic, Serbia
V. Djordjevic, J. Kostic, G. Nikolic
FC-11
Free Communications
08:30–10:00
Conference Room 1
Child Psychiatry
Chair:
Eva Ceskova, Czech Republic
Co-Chair: Anastasia Koumoula, Greece
FC-11-001
Psychosis: Clinical evaluation of 130 patients for inborn
errors of metabolism
Yannis Trakadis, Canada
J. Mitchell
FC-11-002
Alterations of functional responses to glutamate in human
neural progenitors in fragile X syndrome
Maija Castrén, Finland
V. S. Achuta, N. Putkonen
FC-11-003
Perinatal hypoxia differentially regulates the expression of
tyrosine hydroxylase in the hypothalamic, midbrain and
pontine catecholaminergic neurons of the human neonate:
Implications in psychiatry
Maria Panayotacopoulou, Greece
M. Pagida, A. Konstantinidou
FC-11-004
Executive dysfunction in autism spectrum disorders:
A meta-analysis
Eleni Demetriou, Australia
A. Lampit, A. Guastella
FC-11-005
Acute and maintenance electroconvulsive therapy for cat-
atonia in autism spectrum disorders
Lee Wachtel, USA
FC-11-006
The effect of support group therapy on parentally bereaved
adolescents: A randomized controlled trial
Hesham Abuhegazy, Egypt
H. Elkeshishi
FC-11-007
Adverse childhood experiences, depressive symptoms, and
food security status: Cross-sectional analysis of mothers
of children under age 4
Mohini Prasad, USA
A. Evans, M. Chilton